Imaging the progression of intra-tumor heterogeneity in prostate and ovarian xenografts using dynamic contrast-enhanced CT

Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings

Volumn 7 VOLS, Issue , 2005, Pages 1883-1886

  Stantz, Keith M ^a,b   Liang, Yun ^b   Li, Xiong ^b   Kao, Chingai ^b   Steinmetz, Rosemary ^b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; GRAFTS; MATHEMATICAL MODELS; MEDICAL IMAGING;

ANGIOGENESIS; INTRA TUMOR HETEROGENEITY; OVARIAN XENOGRAFTS; PROSTATES;

TUMORS;

EID: 33846934704     PISSN: 05891019     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/iembs.2005.1616818     Document Type: Conference Paper

References (20)

1. C. Vershraegen, V. Vinh-Hung, et al., "Modeling the Effect of Tumor Size in Early Breast Cancer", Annals of Surgery 241(2):309-318, (2005).
2. D.A. Nelson, et al., "Hypoxia and defective apoptosis drive genomic instability and tumorigenesis", Genes Dev 18:2095-2107, (2004).
3. F Balkwill and A. Mantovani, "Inflammation and Cancer: Back to Virchow?", Lancet 357:539-545, (2001).
4. A. Ben-Baruch, "Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions", Breast Cancer Research 5(1): 31-36, (2002).
5. J.L. Yu and J.W. Rak, "Inflammatory and immune cells in tumour angiogenesis and arteriogenesis", Breast Cancer Research 5(2): 83-88, (2003).
6. H. Zhang and A.C. Issekutz, "Down-Modulation of Monocyte Transendothelial Migration and Endothelial Adhesion Molecule Expression by Fibroblast Growth Factor", American Journal of Pathology 160(6): 2219-2230, (2002).
7. A. Abramsson, et al., "Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation", J. Clin. Invest. 112: 1142-1151, (2004).
8. J.R. Gamble, et al., "Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions", Circ Res. 87: 603-607, (2000).
9. G. Brix, et al., "Regional Blodo flow capillary permeability, and compartmental volumes: Measurement with dynamic CT - Initial Experience", Radiology 210(1):269-276, (1999).
10. R.K. Jain and L.L. Munn, "Leaky vessels? Call Ang1", Nature Medicine 6(2): 131-132, (2000).
11. L.J. Metheny-Barlow and L.Y. Li, "The enigmatic role of angiopoietin-1 in tumor angiogenesis", Cell research 13(5): 309-317, (2003).
12. R. K. Jain, "Molecular regulation of vessel maturation", Nature Medicine 9(6): 685-693, (2003).
13. A. Ostman, "PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma", Cytokine & Growth Factor Reviews 15: 275-286, (2004).
14. K. Pietras, et al., "Inhibition of Platelet-derived Growth Factor Receptors Reduces Interstitial Hypertension and Increases Transcapillary Transport in Tumors", Cancer Research 61:2929-2934, (2001).
15. A. Abramsson, et al., "Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors", The Journal of Clinical Investigation 112(8):1142-1151, (2003).
16. R.K. Jain and M.F. Booth, "What brings pericytes to tumor vessels?", The Journal of Clinical Investigation", The Journal of Clinical Investigation 112(8): 1134-1136, (2003).
17. I. Tufto and E.K. Rofstad, "Interstitial fluid pressure and capillary diameter distribution in human melanoma xenografts", Microvascular Research 58(3):205-214, (1999).
18. G. Griffon-Etienne, et al., "Taxane-induced Apoptosis Decopmresses Blood Vessels and Lowers Interstitial Fluid Pressure in Solid Tumors: Clinical Implications", Cancer Research 59:3776-3782, (1999).
19. J. Fang, et al., "HIF-la-mediated Up-Regulation of Vascular Endothelial Growth Factor, Independent of Basic Fibroblast Growth Factor, Is Important in the Switch to the Angiogenic Phenotype during Early Tumorigenesis", Cancer Research 61:5731-5735, (2001).
20. K.M. Stantz, Y. Liang, G. Hutchins, "Kinematic Modeling and Its Implication in Longitudinal Chemotherapy Study of Tumor Physiology: Ovarian Xenograft Mouse Model and Contrast-Enhanced Dynamic CT," Proc. SPIE 5369:769-779, (2004).